- Home
- Publications
- Publication Search
- Publication Details
Title
Immunotherapy and targeted therapy for cervical cancer: an update
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 16, Issue 1, Pages 83-98
Publisher
Informa UK Limited
Online
2015-11-16
DOI
10.1586/14737140.2016.1121108
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
- (2015) S. L. Maude et al. BLOOD
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Immunotherapy: An Evolving Paradigm in the Treatment of Advanced Cervical Cancer
- (2015) Ramez N. Eskander et al. CLINICAL THERAPEUTICS
- Adoptive T-Cell Therapy Is a Promising Salvage Approach for Advanced or Recurrent Metastatic Cervical Cancer
- (2015) Emese Zsiros et al. JOURNAL OF CLINICAL ONCOLOGY
- Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells
- (2015) Sanja Stevanović et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of Cisplatin, Hyperthermia, and Lapatinib in Patients With Recurrent Carcinoma of the Uterine Cervix in a Previously Irradiated Area
- (2015) E. van Meerten et al. ONCOLOGIST
- Phase III placebo-controlled double-blind randomized trial of radiotherapy for stage IIB–IVA cervical cancer with or without immunomodulator Z-100: a JGOG study
- (2014) T. Sugiyama et al. ANNALS OF ONCOLOGY
- The Need for Improvement of the Treatment of Advanced and Metastatic Cervical Cancer, the Rationale for Combined Chemo-Immunotherapy
- (2014) Helene Meir et al. Anti-Cancer Agents in Medicinal Chemistry
- Phase 2 trial of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced cervical cancer
- (2014) Angelica Nogueira-Rodrigues et al. CANCER
- New Strategies in Advanced Cervical Cancer: From Angiogenesis Blockade to Immunotherapy
- (2014) K. S. Tewari et al. CLINICAL CANCER RESEARCH
- Chemotherapy in the treatment of metastatic, persistent, and recurrent cervical cancer
- (2014) Ramez N. Eskander et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Updates in Systemic Treatment for Metastatic Cervical Cancer
- (2014) Angel Chao et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Evidence-Based Therapy for Recurrent Cervical Cancer
- (2014) Bradley J. Monk et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunologic treatments for precancerous lesions and uterine cervical cancer
- (2014) Patrizia Vici et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
- (2014) Caroline Robert et al. LANCET
- Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
- (2014) Huan Shi et al. Molecular Cancer
- Improved Survival with Bevacizumab in Advanced Cervical Cancer
- (2014) Krishnansu S. Tewari et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma
- (2013) S. Lyford-Pike et al. CANCER RESEARCH
- Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199)
- (2013) A.V. Tinker et al. GYNECOLOGIC ONCOLOGY
- Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer
- (2013) Israel Zighelboim et al. GYNECOLOGIC ONCOLOGY
- A synthetic chimeric peptide harboring human papillomavirus 16 cytotoxic T lymphocyte epitopes shows therapeutic potential in a murine model of cervical cancer
- (2013) Chandresh Sharma et al. IMMUNOLOGIC RESEARCH
- Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia
- (2013) Wen Yang et al. IMMUNOLOGY
- RTOG 0417: Efficacy of Bevacizumab in Combination With Definitive Radiation Therapy and Cisplatin Chemotherapy in Untreated Patients With Locally Advanced Cervical Carcinoma
- (2013) Tracey Schefter et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- At the Bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy
- (2013) Margaret K. Callahan et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Human papillomavirus and cervical cancer
- (2013) Emma J Crosbie et al. LANCET
- Landscape of genomic alterations in cervical carcinomas
- (2013) Akinyemi I. Ojesina et al. NATURE
- Impact of Genomics on Personalized Cancer Medicine
- (2012) C. L. Arteaga et al. CLINICAL CANCER RESEARCH
- mTOR as a Molecular Target in HPV-Associated Oral and Cervical Squamous Carcinomas
- (2012) A. A. Molinolo et al. CLINICAL CANCER RESEARCH
- Treatment of metastatic cervical cancer: Future directions involving targeted agents
- (2012) Ivan Diaz-Padilla et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- PIK3CA mutational status and overall survival in patients with cervical cancer treated with radical chemoradiotherapy
- (2012) John B. McIntyre et al. GYNECOLOGIC ONCOLOGY
- A Phase II Study of Bevacizumab in Combination With Definitive Radiotherapy and Cisplatin Chemotherapy in Untreated Patients With Locally Advanced Cervical Carcinoma: Preliminary Results of RTOG 0417
- (2012) Tracey E. Schefter et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human papillomavirus 16 L1–E7 chimeric virus like particles show prophylactic and therapeutic efficacy in murine model of cervical cancer
- (2012) Chandresh Sharma et al. VACCINE
- Therapy of Human Papillomavirus-Related Disease
- (2012) Peter L. Stern et al. VACCINE
- A prime/boost strategy by DNA/fowlpox recombinants expressing a mutant E7 protein for the immunotherapy of HPV-associated cancers
- (2012) Antonia Radaelli et al. VIRUS RESEARCH
- Targeted treatments for cervical cancer: a review
- (2012) Oscar Peralta-Zaragoza et al. OncoTargets and Therapy
- Immunization with a poly (lactide co-glycolide) encapsulated plasmid DNA expressing antigenic regions of HPV 16 and 18 results in an increase in the precursor frequency of T cells that respond to epitopes from HPV 16, 18, 6 and 11
- (2011) Mark Matijevic et al. CELLULAR IMMUNOLOGY
- Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: A Gynecologic Oncology Group study
- (2011) John Farley et al. GYNECOLOGIC ONCOLOGY
- Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
- (2011) Alessandro D. Santin et al. GYNECOLOGIC ONCOLOGY
- Papillomavirus E5: the smallest oncoprotein with many functions
- (2011) Aldo Venuti et al. Molecular Cancer
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- New Approaches to Immunotherapy for HPV Associated Cancers
- (2011) Anne-Sophie Bergot et al. Cancers
- Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment
- (2010) Mi-Kyung Kim et al. BIOCHEMICAL PHARMACOLOGY
- Immunotherapy for Cervical Cancer
- (2010) Jun-Han Su et al. BIODRUGS
- Different spectra of therapeutic vaccine development against HPV infections
- (2010) Azam Bolhassani et al. Human vaccines & immunotherapeutics
- A Phase II Trial of Erlotinib in Recurrent Squamous Cell Carcinoma of the Cervix
- (2010) Russell J. Schilder et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Phase II, Open-Label Study of Pazopanib or Lapatinib Monotherapy Compared With Pazopanib Plus Lapatinib Combination Therapy in Patients With Advanced and Recurrent Cervical Cancer
- (2010) Bradley J. Monk et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- HPV-16 E5 down-regulates expression of surface HLA class I and reduces recognition by CD8 T cells
- (2010) M.S. Campo et al. VIROLOGY
- Persistence of High-Grade Cervical Dysplasia and Cervical Cancer Requires the Continuous Expression of the Human Papillomavirus Type 16 E7 Oncogene
- (2009) S. F. Jabbar et al. CANCER RESEARCH
- Costimulation as a Platform for the Development of Vaccines: A Peptide-Based Vaccine Containing a Novel Form of 4-1BB Ligand Eradicates Established Tumors
- (2009) R. K. Sharma et al. CANCER RESEARCH
- Tumor-Expressed B7-H1 and B7-DC in Relation to PD-1+ T-Cell Infiltration and Survival of Patients with Cervical Carcinoma
- (2009) R. Karim et al. CLINICAL CANCER RESEARCH
- Will targeted therapy hold its promise? An evidence-based review
- (2009) David Murdoch et al. CURRENT OPINION IN ONCOLOGY
- Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial
- (2009) J.E. Kurtz et al. GYNECOLOGIC ONCOLOGY
- Long-Term Protection Against Human Papillomavirus E7-Positive Tumor by a Single Vaccination of Adeno-Associated Virus Vectors Encoding a Fusion Protein of Inactivated E7 of Human Papillomavirus 16/18 and Heat Shock Protein 70
- (2009) Liqiao Zhou et al. HUMAN GENE THERAPY
- Phase II Trial of Bevacizumab in the Treatment of Persistent or Recurrent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
- (2009) Bradley J. Monk et al. JOURNAL OF CLINICAL ONCOLOGY
- Human Papillomavirus Type 16 (HPV-16) Virus-Like Particle L1-Specific CD8+ Cytotoxic T Lymphocytes (CTLs) Are Equally Effective as E7-Specific CD8+ CTLs in Killing Autologous HPV-16-Positive Tumor Cells in Cervical Cancer Patients: Implications for L1 Dendritic Cell-Based Therapeutic Vaccines
- (2009) S. Bellone et al. JOURNAL OF VIROLOGY
- Negative Prognostic Impact of the Coexpression of Epidermal Growth Factor Receptor and c-erbB-2 in Locally Advanced Cervical Cancer
- (2009) José Pérez-Regadera et al. ONCOLOGY
- Somatic LKB1 Mutations Promote Cervical Cancer Progression
- (2009) Shana N. Wingo et al. PLoS One
- Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses
- (2009) Mitsuhiro Nakamura et al. VIROLOGY
- Development of an Adenoviral Vaccine Against E6 and E7 Oncoproteins to Prevent Growth of Human Papillomavirus–Positive Cancer
- (2008) Dong Wook Lee et al. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
- Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy
- (2008) Chel Hun Choi et al. BMC CANCER
- Single-Dose, Therapeutic Vaccination of Mice with Vesicular Stomatitis Virus Expressing Human Papillomavirus Type 16 E7 Protein
- (2008) J. B. Liao et al. Clinical and Vaccine Immunology
- Intravaginal Immunization of Mice with Recombinant Salmonella enterica Serovar Typhimurium Expressing Human Papillomavirus Type 16 Antigens as a Potential Route of Vaccination against Cervical Cancer
- (2008) H. Echchannaoui et al. INFECTION AND IMMUNITY
- Induction of Cytotoxic T-Lymphocytes and Antitumor Activity by a Liposomal Lipopeptide Vaccine
- (2008) Weihsu Chen et al. MOLECULAR PHARMACEUTICS
- The Promise and Perils of ‘Targeted Therapy’ of Advanced Ovarian Cancer
- (2008) Maurie Markman ONCOLOGY
- A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer
- (2007) A. Goncalves et al. GYNECOLOGIC ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now